Morpholino-based antisense oligomers are a best-in-class technology for the therapeutic modulation of splicing, and their use is now approved to treat Duchenne Muscular Dystrophy caused by specific defects in the dystrophin gene [19]. Here, DMD is linked to Duchenne muscular dystrophy.